| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |